Clinical Trials Insight: 700027241

Trial Profile

Clinical Trials Insight: 700027241

Planning
Phase of Trial: Phase II

Latest Information Update: 21 May 2008

At a glance

  • Drugs Arimoclomol (Primary)
  • Indications Stroke
  • Focus Therapeutic Use
  • Sponsors CytRx Corporation
  • Most Recent Events

    • 21 May 2008 The trial is now expected to be initiated in the second half of 2008, according to a CytRx media release.
    • 02 Oct 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top